Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-9788
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database ; volume:5 ; number:2 ; day:3 ; month:5 ; year:2018 ; pages:117-128 ; date:6.2018
Drugs - real world outcomes ; 5, Heft 2 (3.5.2018), 117-128, 6.2018
- Creator
-
Toki, Tadashi
- Contributor
-
Ono, Shunsuke
SpringerLink (Online service)
- DOI
-
10.1007/s40801-018-0134-0
- URN
-
urn:nbn:de:101:1-2018081007575788587635
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Toki, Tadashi
- Ono, Shunsuke
- SpringerLink (Online service)
Other Objects (12)
Standardizing adverse drug event reporting data
Consumers’ adverse drug event reporting via community pharmacists: three stakeholder perception
Seasonal and Geographic Variation in Adverse Event Reporting
Influenza Vaccination Behavior and Media Reporting of Adverse Events
Analysis of post-market adverse events of tafamidis base on the FDA adverse event reporting system
Statistical methods for exploring spontaneous adverse event reporting databases for drug-host factor interactions
Evaluation of lung adverse events with nivolumab using the spontaneous reporting system in Japan
A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions
Analysis of adverse drug events in pulmonary Mycobacterium avium complex disease using spontaneous reporting system
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Standardizing adverse drug event reporting data
Consumers’ adverse drug event reporting via community pharmacists: three stakeholder perception
Seasonal and Geographic Variation in Adverse Event Reporting
Influenza Vaccination Behavior and Media Reporting of Adverse Events
Analysis of post-market adverse events of tafamidis base on the FDA adverse event reporting system
Statistical methods for exploring spontaneous adverse event reporting databases for drug-host factor interactions
Evaluation of lung adverse events with nivolumab using the spontaneous reporting system in Japan
A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions
Analysis of adverse drug events in pulmonary Mycobacterium avium complex disease using spontaneous reporting system
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Standardizing adverse drug event reporting data
Consumers’ adverse drug event reporting via community pharmacists: three stakeholder perception
Seasonal and Geographic Variation in Adverse Event Reporting
Influenza Vaccination Behavior and Media Reporting of Adverse Events
Analysis of post-market adverse events of tafamidis base on the FDA adverse event reporting system
Statistical methods for exploring spontaneous adverse event reporting databases for drug-host factor interactions
Evaluation of lung adverse events with nivolumab using the spontaneous reporting system in Japan
A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions
Analysis of adverse drug events in pulmonary Mycobacterium avium complex disease using spontaneous reporting system